Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPPAR: Pioglitazone in Rheumatoid Arthritis
NCT00554853Phase 3Completed
- Sponsor
- University of Michigan
- Start
- Nov 2007
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in rheumatoid arthritis (RA), sponsored by University of Michigan. Started Nov 2007; status: completed.
02
Drugs
pioglitazone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00554853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554853.